Sat.Dec 12, 2020 - Fri.Dec 18, 2020

article thumbnail

Machine-learning, robotics and biology to deliver drug discovery of tomorrow

pharmaphorum

Biology 2.0: Combining machine-learning, robotics and biology to deliver drug discovery of tomorrow. Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment. Medicines discovery innovators, Intelligent OMICS, supported by Arctoris and Medicines Discovery Catapult, are applying artificial intelligence to find new disease ‘drivers’ and candidate drugs for lung cancer.

article thumbnail

Best Features of Mobile Workstations in Pharmaceutical Production

Pharma Mirror

The future of pharmaceutical manufacturing is mobile. Advances in cloud computing and the onset of Industry 4.0 has led to the proliferation of mobile IT solutions for manufacturing, including pharmaceuticals. Particularly, mobile workstations and tablets are becoming staples of the pharmaceutical manufacturing workflow due to their cost-effectiveness, particularly in demanding environments like cleanrooms, where even modular fixed human-machine interfaces (HMIs) can be exorbitantly priced and c

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Researchers ‘must embrace the change’ in the year ahead: PRA

Outsourcing Pharma

The head of the CROâs Global Center of Excellence for Decentralized Clinical Trial Strategy outlines key developments in 2020, and keys to success in 2021.

98
article thumbnail

Amitriptyline for NERVE PAIN (REVIEWED)

Druggist

Amitriptyline is one of the most popular antidepressants in the UK. Its use is not just restricted to the treatment of depression. Amitriptyline is one of the first options considered when a drug treatment is needed to help manage neuropathic pain. This post focuses on the use of amitriptyline for nerve pain. Summary of the post: What is amitriptyline?

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

ABPI chief exec on the UK industry’s learnings from COVID-19

pharmaphorum

The ABPI’s chief executive Dr Richard Torbett shares his views on how the industry has adapted to COVID-19 and explains why the post-pandemic future is looking bright for the UK industry. January 2020 would have been an interesting time for anyone to start a new job, but for Richard Torbett, who moved into the chief executive position at the ABPI after five years at the Association, it meant taking the helm of an organisation that quickly found itself on the frontline of global efforts to fight

Vaccines 122
article thumbnail

NextGen Pharma Content | March 23-24, 2021 | Virtual Summit

Pharma Marketing Network

The 2021 NextGen Pharma Content , taking place on March 23-24 , will bring together content creators, marketers, and communications/PR practitioners to learn how to build trust and earn loyalty with customers to achieve a positive emotional connection with your brand. Don’t miss out on gaining unique insights from these experts, as well as the many opportunities to network with your peers and stakeholders working on content.

More Trending

article thumbnail

Pharmacy Staffing Delivers

indispensable health

Ensuring hospitals are adequately staffed in all of their departments is essential every day and it becomes even more critical during times of crisis, like a global pandemic, or during times where it’s common for many staff members to request time off. For over twenty years, Indispensable Health’s day-to-day staffing service has provided pharmacy professionals to pharmacies of all types and sizes.

article thumbnail

Pharma still reluctant to back gamification for health; interview

pharmaphorum

The pharma industry has been making great strides forward in digital health, but one element of that – gamification – hasn’t yet made much headway in the sector. Armed with new data from a randomised clinical trial, one company is hoping to change that mindset. The company is FriendsLearn – based in India and with an R&D office in San Francisco – which recently reported results from a trial showing that its fooya!

article thumbnail

COVID-19 winter lockdowns & national restrictions drive demand for ‘body and mind’ formulations say SIRIO Europe

Pharma Mirror

Manufacturers seeking CDMOs that can quickly develop complex formulations offering both body and mind benefits SIRIO Europe (Ayanda) – the European nutraceutical and pharmaceutical contract development and manufacturing organisation (CDMO) and member of SIRIO Group – forecasts a winter surge in requests from nutra brands for new ‘dual benefit’ mood enhancing formulations as a result of COVID-19 measures.

52
article thumbnail

Looking back, thinking ahead: industry leaders talk trends

Outsourcing Pharma

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

96
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Pandemic has made little positive impact on public's view of pharma

Pharma Times

A new report launched by Takeda has found that just 17% of UK adults surveyed felt their perception of pharma had improved based on the industry's response to COVID-19

63
article thumbnail

Alexion finally has a buyer – and it’s AstraZeneca with $39bn on the table

pharmaphorum

Alexion has routinely featured among lists of top biopharma takeover prospects in the last couple of years, and that was a good call – AstraZeneca has just swooped in with $39 billion cash-and-stock takeover offer. The deal – the largest in the pharma sector since the start of the pandemic – bolsters AZ’s immunology franchise with $4 billion blockbuster Soliris (eculizumab) and longer acting follow-up Ultomiris (ravulizumab), plus a pipeline of 11 drugs for rare and autoimmune diseases.

110
110
article thumbnail

SGLT2s And The Prescribing Cascade

Med Ed 101

SGLT2s like empagliflozin, dapagliflozin, ertugliflozin, and canagliflozin are getting more use in diabetes care as time goes on. As a geriatric pharmacist, I certainly recognize that these agents have a lot of potential benefits, but they can also have adverse outcomes. I wanted to touch briefly on two examples of the SGLT2s and the prescribing […].

40
article thumbnail

Industry survey delves into wearable device use

Outsourcing Pharma

The research (conducted by trial tech provider Litmus Health) shows an indepth picture of wearable device use, top devices, data capture and other factors.

90
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Green light for UK trial of nasal coronavirus vaccine

Pharma Times

The trial is expected to begin next month, with first data anticipated in the second quarter of 2020

article thumbnail

Would you fall for COVID misinformation? Chatbot can help you find out

pharmaphorum

Researchers in the UK have developed a chatbot-enabled website that can train people to detect and counter misinformation on COVID-19 and other topics, using techniques from some of philosophy’s greatest critical thinkers. Earlier this year, the World Health organisation (WHO) said the world was dealing with an “infodemic” that is accompanying the pandemic and it is hard for the general public to recognise the “grey area of” misinformation.

article thumbnail

Hyperthermia and Medications Case Scenario

Med Ed 101

A 53-year-old male presents to the emergency department with severe agitation, fever, and symptoms of delirium. The attending provider assesses the patient and gets a urine drug screen. The drug screen was positive for cocaine. In addition to the psychiatric symptoms, tachycardia and fever (101.6 degrees Fahrenheit) are present. Hyperthermia is particularly concerning to the […].

40
article thumbnail

2020 was ‘the year our industry got it right’: pharma veteran

Outsourcing Pharma

William Carson says while the past year was full of challenges, embracing AI and other advanced technology led to impressive progress and opportunity.

87
article thumbnail

EU for AZ' COPD maintenance therapy

Pharma Times

The triple combination therapy Trixeo Aerosphere cut the rate of moderate or severe exacerbations compared with dual-combination therapies in clinical trials

49
article thumbnail

Family doctors begin COVID-19 immunisation drive in UK

pharmaphorum

The roll-out of the biggest vaccination programme in the history of the UK’s NHS is gathering pace, as family doctors and their teams begin taking delivery of Pfizer/BioNTech’s COVID-19 shot. In a statement the NHS said that GP practices in more than 100 parts of the country are taking delivery of the vaccine today. Some clinics will begin immunisations this afternoon and the majority will start tomorrow (Tuesday), the NHS said.

Vaccines 105
article thumbnail

Codeine over the counter – 17 OTC products

Druggist

Without a doubt, codeine-containing products are one of the most commonly sold medicines in the UK. Codeine can be purchased over the counter in the UK. Most codeine products are combination products of codeine and another drug. Codeine over the counter can only be purchased on its own in one form; please read on. I will list most of the codeine over the counter product in the UK; specifically, I will talk about: Forms of codeine available over the counter in the UK.

Dosage 98
article thumbnail

Rho joins Decentralized Trials and Research Alliance

Outsourcing Pharma

The newly formed group seeks to bring together research professionals to accelerate adoption and introduce industry standards in virtual and hybrid trials.

84
article thumbnail

EUSA Pharma launches phase III COVID-19 study for siltuximab

Pharma Times

Study will enrol hospitalised COVID-19 patients with serious viral acute respiratory distress syndrome

53
article thumbnail

Daiichi Sankyo, AZ close on EU approval of Enhertu for breast cancer

pharmaphorum

Daiichi Sankyo and AstraZeneca could be just weeks away from an EU approval for their antibody-drug conjugate (ADC) for breast cancer – Enhertu – which is tipped to become a multibillion-dollar blockbuster. At its meeting last week, the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended approval of Enhertu (trastuzumab deruxtecan) for patients with unresectable or metastatic HER2-positive breast cancer, who have been previously treated with other anti-HER2 drugs.

FDA 105
article thumbnail

Highlights from Reuters Events, Pharma Awards USA 2020

Pharma Marketing Network

Highlights from Reuters Events, Pharma Awards USA 2020 – Day 1. With access to over 60 of the industry’s shining case studies, the 2020 USA Pharma Awards held its virtual ceremony on December 8-9, 2020. Throughout the ceremony, finalists presented their learnings around patient experience & services, novel collaborations, customer experience, education & awareness, analytics, and more.

article thumbnail

Data explosion leads to opportunities, obstacles: ACD/Labs

Outsourcing Pharma

A representative from the small-molecule solutions company explains how the ever-increasing mountain of life-sciences data has impacted drug development.

83
article thumbnail

Novo Nordisk eyes EU approval for once-weekly semaglutide

Pharma Times

Danish pharma is seeking approval for drug as a weight management therapy

57
article thumbnail

EUSA Pharma hopes IL-6 drug will succeed in COVID-19 where rivals failed

pharmaphorum

UK-based EUSA Pharma has begun a late-stage trial of its antibody siltuximab in COVID-19, hoping that the IL-6 inhibitor will succeed where class rivals from Roche and Sanofi/Regeneron have failed. Hertfordshire-based EUSA said recruitment has begun in phase 3 trial involving patients with COVID-19 previously treated with corticosteroids and other respiratory viruses associated with serious respiratory complications.

article thumbnail

Trials of Valneva COVID-19 vaccine begin in UK

pharmaphorum

Trials of a fifth COVID-19 vaccine have begun in the UK, as IT issues threaten to delay the roll-out of the shot from Pfizer/BioNTech. France’s Valneva begun the phase 1/2 clinical study of the inactivated vaccine candidate VLA2001 in sites across the UK, supported by the National Institute for Health Research (NIHR). It is the first publicly announced inactivated COVID-19 vaccine candidate to begin clinical development in Europe.

Vaccines 104
article thumbnail

Ardelyx’s ambition to revolutionise kidney treatment

pharmaphorum

A therapy to treat hyperphosphatemia is moving closer to the market after years of development by California-based company Ardelyx. The company’s lead candidate Tenapanor is a targeted, small molecule therapy currently under FDA review. As the pandemic surged this year, the disruption of healthcare systems posed a significant challenge for patients receiving kidney care.

FDA 95
article thumbnail

Amgen files KRAS trailblazer sotorasib with FDA for lung cancer

pharmaphorum

Amgen has filed its groundbreaking KRAS inhibiting drug sotorasib with the FDA for a group of lung cancer patients with an aggressive form of the disease. The drug was the first targeted at the mutation known as KRAS to show activity in the clinic and provided the biggest talking point at the American Society of Clinical Oncology (ASCO) conference in 2019.

FDA 98
article thumbnail

FDA backs Moderna COVID-19 shot ahead of emergency use vote

pharmaphorum

Moderna looks odds on to claim emergency use authorisation from the FDA for its COVID-19 vaccine this week, after the regulator published a report endorsing its safety and rating its efficacy at 94.5%. The document has been published just after the US started the rollout of Pfizer and BioNTech’s vaccine after it got an emergency green light last week, and ahead of an expert panel due to consider Moderna’s shot on Thursday.

FDA 93
article thumbnail

VC fund dedicated to psychedelic meds launches in UK

pharmaphorum

In the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms – magic or otherwise – and venture capital money is starting to follow. Today sees the launch of the first investment fund in the UK devoted to psychedelic healthcare, with plans to invest in “revolutionary mind-altering medicines to treat illnesses including depression, addiction, anxiety and inflammation.”.

88
article thumbnail

Scientists and medics turn to TikTok to reassure public on vaccine safety

pharmaphorum

Tik Tok is unlikely to spring to mind as a source of reliable information about complex issues, but scientists are using it to fly the flag for COVID-19 vaccines and other health topics. The social media platform, which allows users to share short and often frivolous video clips, has a growing number of experts using it to communicate important information to a broad audience, and particular teenagers and young adults.